10-YEAR CLINICAL EVENTS AVOIDED IN DIABETIC AND CHRONIC KIDNEY DISEASE HYPERTENSION PATIENTS TREATED WITH RADIOFREQUENCY RENAL DENERVATION: PROJECTIONS BASED ON 3-YEAR DATA FROM THE GLOBAL SYMPLICITY REGISTRY (2022) Schmieder R, Cao K, Esler M, Kandzari D, Lobo M, Sharp A, Mancia G, et al. Conference contribution VISUALISING AND DIFFERENTIATING KIDNEY DISORDERS BY URINARY PEPTIDOMICS USING A MACHINE LEARNING APPROACH (2022) Siwy J, Mavrogeorgis E, He T, Mischak H, Rupprecht H, Beige J Conference contribution EXPECTATION AND ACCEPTANCE OF A CLINICAL DECISION SUPPORT SOFTWARE BY NEPHROLOGIST END-USERS: THE CKDNAPP SURVEY (2022) Kotsis FK, Beachle H, Altenbuchinger M, Meiselbach H, Kosch R, Sabine S, Tanja B, Schultheiss UT Conference contribution PRECLINICAL EFFICACY OF DIRECT AMPK ACTIVATION WITH A NOVEL SMALL MOLECULE-PXL770-FOR THE TREATMENT OF AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE (2022) Dagorn PG, Buchholz B, Bange H, Blockken L, Moller DE, Hallakou-Bozec S Conference contribution LONGITUDINAL INTRAINDIVIDUAL CHANGES OF PERITONEAL HISTOLOGY OVER TIME IN 37 PERITONEAL DIALYSIS PATIENTS (2022) Aziz A, Kielstein JT, Pfister F, Amann KU, Eden G Conference contribution GENERATION OF PATIENT-SPECIFIC HIPSC-PODOCYTES TO STUDY PHENOTYPE-SPECIFIC ALTERATIONS AND TEST THERAPEUTIC TARGETS EX VIVO (2022) Rose V, Sopel N, Ohs A, Warnecke C, Schiffer M, Müller-Deile J Conference contribution Alport syndrome and autosomal dominant tubulointerstitial kidney disease frequently underlie end-stage renal disease of unknown origin-a single-center analysis (2022) Leenen E, Erger F, Altmuller J, Wenzel A, Thiele H, Harth A, Tschernoster N, et al. Journal article Renal denervation: where do we stand and what is the relevance to the nephrologist? (2022) Schmieder R Journal article, Review article Renal denervation in patients with versus without chronic kidney disease: results from the Global SYMPLICITY Registry with follow-up data of 3 years (2022) Ott C, Mahfoud F, Mancia G, Narkiewicz K, Ruilope LM, Fahy M, Schlaich MP, et al. Journal article Interim analysis of the COSA (COVID-19 patients treated with the Seraph(R) 100 Microbind(R) Affinity filter) registry (2021) Schmidt JJ, Borchina DN, Van'T Klooster M, Bulhan-Soki K, Okioma R, Herbst L, Rodriguez DS, et al. Journal article